Tag: Cancer: Cervical
Copper Intrauterine Devices Tied to Lower Risk for Cervical Cancer
Findings based on comparison to hormonal intrauterine devices
Single Dose of HPV Vaccine May Cut Preinvasive Cervical Disease
Risk for preinvasive cervical disease decreased with one, two, three vaccine doses at age 15 to 19 years
Modeling Studies Show Cervical Cancer Could Be Eliminated
And mortality could be reduced by about one-third by 2030 and almost completely by 2120
Whether HPV Vaccination Will Prevent Cervical Cancer Unclear
Review highlights limitations of trial design; additional research needed to address uncertainties
Cervical Cancer Screening Remains Low in Women Ages 45 to 65 Years
Screening rates are insufficient to reduce cervical cancer incidence
Cervical Cancer Screening Remains Low in Women Ages 45 to 65 Years
Screening rates are insufficient to reduce cervical cancer incidence
Most HPV-Linked Cancers Due to Types Targeted by 9vHPV Vaccine
In 2012 to 2016, 92 percent of cancers attributable to HPV due to HPV types targeted by 9vHPV vaccine
DNA Methylation Classifier Predicts Progression in CIN2
For regression versus progression outcome, highest AUC was 0.735 for combination of S5, cytology
Psychologic Distress Linked to Cervical Cancer Mortality
Risk up with diagnosis of stress-related disorders or an occurrence of stressful life events around diagnosis
One Dose of HPV Vaccine May Be Sufficient in Certain Situations
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings
